selected publications
-
CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response.
Oncoimmunology.
2023
Academic Article
GET IT
Times cited: 4 -
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors.
Nature communications.
2023
Academic Article
GET IT
Times cited: 35 -
Radiation therapy-induced remodeling of the tumor immune microenvironment.
Seminars in cancer biology.
2022
Review
GET IT
Times cited: 90 - hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote its translation in stressed melanoma cells. Molecular oncology. 2021 Academic Article GET IT
-
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.
The Journal of clinical investigation.
2021
Academic Article
GET IT
Times cited: 195 -
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection.
Oncoimmunology.
2020
Review
GET IT
Times cited: 7 -
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 35 -
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells.
Oncoimmunology.
2019
Academic Article
GET IT
Times cited: 47 - Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France. Immunotherapy. 2017 Conference Paper GET IT
-
IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 49 -
The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.
PloS one.
2013
Academic Article
GET IT
Times cited: 30